1 |
3-(Diethylboraneyl)pyridine |
89878-14-8 |
KSM of Abiraterone Acetate |
2 |
(3S,8R,9S,10S,13S,14S,Z)-17-hydrazineylidene-10,13-dimethyl-2-3,4,5,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[ɑ]phenantheren-3-ol |
NA |
Intermediate of Abiraterone Acetate |
3 |
(3S,8R,9S,10S,13S,14S)-17-iodo-10,13-dimethyl-2-3,4,5,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[ɑ]phenantheren-3-ol |
32138-69-5 |
Intermediate of Abiraterone Acetate |
4 |
(3S,8R,9SI0S,13S,14S)-10,13-dimethyl-17-
(pyridin-3-yl)-2,3,4,5,8,9,10,1 1,12,13,14,15-
dodecahydro- IH- cyc1openta[a]phenanthren-3- ol |
NA |
Intermediate of Abiraterone Acetate |
5 |
2,2′ (5 methyl- 1,3-phenylene)bis(2- methylpropanenitrile) |
120511-72-0 |
KSM of Anastrozole |
6 |
2,2′-(5-(bromomethyl)-1,3-pheny1ene) bis(2-methylpropanenitrile) |
120511 -84-4 |
Intermediate of Anastrozole |
7 |
4-Amino-2-fIuoro-N-methyIbenzamide |
915087-25-1 |
KSM of Apalutamide |
8 |
2-Fluoro-N-methyl-4-nitrobenzamide |
915087-24-0 |
KSM of Apalutamide |
9 |
5-Amino-3-(trifluoromethyl)picolinonitriìe |
573762-62-6 |
KSM of Apalutamide |
10 |
5-Nitro-3-(trif1uoromethyl)picolinonitrile |
573762-57-9 |
KSM of Apalutamide |
11 |
2-Bromo-5-nitro-3-(trif1uoromethyl)pyridine |
956104-42-0 |
KSM of Apalutamide |
12 |
4-((1-cyanocycIobutyI)amino)-2-fìuoro-N-methyIbenzamide |
915087-26-2 |
Intermediate for Apalutamide |
13 |
(3R,4R,5R)-5-(acetoxymethyl) tetrahydrofuran-2,3,4-triyl triacetate |
28708-32-9 |
KSM of Azacitidine |
14 |
5-Azacytosine |
931-86-2 |
KSM of Azacitidine |
15 |
Guanyl urea formate |
NA |
RM of Azacitidine |
16 |
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate |
10302-78-0 |
Intermediate of Azacitidine |
17 |
Ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
3543-73-5 |
KSM of Bendamustine |
18 |
Ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
3543-74-6 |
lntermediate of Bendamustine |
19 |
Ethyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
87475-54-5 |
lntermediate of Bendamustine |
20 |
N-(4-Cyano-3-(trifluromethyl)phenyl)methacrylamide |
90357-53-2 |
KSM OF Bicalutamide |
21 |
N-(4-Cyano-3-(trifluromethyl)phenyl)-2-methyloxirane-2-carboxamide |
90357-51-0 |
KSM OF Bicalutamide |
22 |
(3aS,4s,6s,7aR)-2-isobutyl-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]diaoxaborole |
84110-34-9 |
KSM of Bortezomib |
23 |
(3aS,4s,6s,7aR)-2-((S)-1-chloro-3-methylbutyl)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]diaoxaborole |
85167-14-2 |
KSM of Bortezomib |
24 |
(R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-amine |
179324-86-8 |
ADI of Bortezomib |
25 |
N-((2S)-1-(((1R)-3-methyl-1-((3aS,4S,6S)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
NA |
intermediate of Bortezomib API |
26 |
Methyl L-phenylalaninate. HCI |
7524-50-7 |
KSM of Bortezomib |
27 |
Methyl (pyrazine-2-carbonyI)- L-phenylalaninate |
73058-37-4 |
KSM of Bortezomib |
28 |
(Pyrazine-2-carbonyl) L-phenylalanine |
1093959-75-1 |
ADI of Bortezomib |
29 |
((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro [3,4-d] [1,3] dioxol-4-yl)methyl 4-methylbenzenesulfonate |
4137-56-8 |
KSM of Capecitabine |
30 |
(3aR,6R,6aR)-4-methoxy-2,2,6-trimethyl tetrahydrofuro[3,4-d][1, 3]dioxole |
NA |
KSM of Capecitabine |
31 |
(2S,3R,4R,5R )-5-methyltetrahydrofuran- 2,3,4-triyl triacetate |
62211-93-2 |
KSM of Capecitabine |
32 |
(2R,3R,4R,5R )-2- (4-amino-5-fluoro-2-oxopyrimidin- 1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate |
161599-46-8 |
ADI of Capecitabine |
33 |
Cyclobutane-1,1-dicarboxylic acid |
5445-51-2 |
KSM of Carboplatin |
34 |
I,3-bis(2-chloroethyl)urea |
2214-72-4 |
KSM of Carmustine |
35 |
tert-butyl 4-((methylsu1fonyl)oxy) piperidine- 1-carboxylate |
141699-59-4 |
KSM of Crizotinib |
36 |
tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1- carboxylate |
877399-73-0 |
KSM of Crizotinib |
37 |
(S)-1-(2,6-dichloro-3-f1uorophenyl)ethan-I-ol |
877397-65-4 |
RM of Crizotinib |
38 |
(R)-3-(1 -(2,6-dichloro-3-fluorophenyl) ethoxy)-2-nitropyridine |
877397-70-1 |
KSM of Crizotinib |
39 |
(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
877397-71-2 |
KSM of Crizotinib |
40 |
(R)-5- bromo-3-(1-(2 ,6-dichloro-3- fiuorophenyl)ethoxy)pyridin-2-amine |
877399-00-3 |
KSM of Crizotinib |
41 |
2-Chloro-4- (1H- pyrazol-3-yl)benzonitrile |
1297537-37-1 |
KSM of Darolutamide |
42 |
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-ch1orobenzonitri1e |
1297537-41-7 |
KSM of Darolutamide |
43 |
(E)-3-ethoxyacryloyl chloride |
6191-99-7 |
KSM of Dasatinib |
44 |
(E)-N-(2-chloro-6-methylphenyl)-3- ethoxyacrylamide |
863127-76-8 |
KSM of Dasatinib |
45 |
2-amino-N-(2-ch1oro-6-methylphenyl)thiazole-5- carboxamide |
302964-24-5 |
KSM of Dasatinib |
46 |
2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6- methylphenyl)thiazole-5-carboxamide |
302964-08-5 |
Intermediate of Dasatinib |
47 |
2-Methylpyrimidine-4,6-diol |
40497-30-1 |
SM of Dasatinib |
48 |
4,6-Dichloro-2-methylpyrimidine |
1780-26-3 |
KSM of Dasatinib |
49 |
2-(piperazin-1-yl)ethan-1-o1 |
103-76-4 |
KSM of Dasatinib |
50 |
(2aR,4S,4aS,6R,9S,11S,12S,12aR, 12bS)-12b-acetoxy-9,11-dihydroxy- 4a,8,13,l3-tetramethyl-5-oxo-4,6-bis(((2,2,2-trichloroethoxy)carbonyl)oxy)- 2a,3,4,4a,5,6,9,10,11,12,12a, 12b-dodecahydro- 1H-7,11- methanocyclodeca[3,4]benzo[1,2 -b]oxet- 12-yl benzoate |
NA |
KSM of Docetaxel |
51 |
5-((2aR,4S,4aS,6R,9S,11S, 12S,12aR ,12bS)- 12b-acetoxy- 12- (benzoyloxy)-11 -hydroxy-4a,8,13,13- tetramethyl-5- oxo-4,6-bis(((2,2,2 -trichloroethoxy)carbony1)oxy)2a,3,4,4a,5,6,9,l0,11,12,12a, 12b-dodecahydro-1H-7,11- methanocyclodeca[3,4]benzo[1,2-b]oxet-9-yl) 3-(tert-butyl)(4S,5R)-2-(4-methoxyphenyl)-4-phenyloxazolidine-3,5-dicarboxylate |
NA |
KSM of Docetaxel |
52 |
Benzenepropanoic acid, b-[[( 1,1-diMethylethoxy) carbonyI]aMino]-a-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)- 12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12, l2a,12b-, Docetaxel intermcdiate |
114915-14-9 |
Intermediate of Docetaxel |
53 |
4-Amino-2-(trifluoromethyl)benzonitrile |
|
654-70-6 |
KSM of Enzalutamide |
54 |
4-Nitro-2-(trifluoromethyl)benzonitrile |
320-37-6 |
KSM of Enzalutamide |
55 |
4-Bromo-3 -(trifluoromethyI)aniline |
393-36-2 |
KSM of Enzalutamide |
56 |
4-((2-cyanopropan-2-yl)amino)- 2-f1uoro-N-methylbenzamide |
915087-32-0 |
Intermediate of Enzalutamide |